Reproductive Health Innovation Summit 2024

Reproductive Health Innovation Summit

Connecting industry c-suite to showcase disruptive innovations, forge critical partnerships and drive sector growth across reproductive health

Download 2024 Agenda
Boston, USA
13-14 February, 2024

“If you want to be part of this ecosystem and if you are truly into driving advances in women's health but specifically in reproductive medicine, then this is the place for you”

Ferring Pharmaceuticals

THE REPRODUCTIVE HEALTH INNOVATION SUMMIT 2024

RHIS provides a platform that enables the industry to collectively improve reproductive health outcomes across both male and female sectors. Through uplifting partners, facilitating connections, and providing access to senior leaders, RHIS enables businesses to thrive. As we look forward to the 4th RHIS, we continue to uphold its commitment to meeting the essential demands of the reproductive health landscape.

ARE YOU INTERESTED IN ANY OF THESE 3 REPRODUCTIVE HEALTH TOPICS?

This year, RHIS will continue to address the most pressing industry topics and champion the most disruptive innovation. Broadly split between the three main pillars of reproductive health, this year, we’re covering  covering male and female reproductive health, within the broader framework of three pillars:

  • Family Planning and Fertility
    Deep dive into: Infertility (male and female), IVF (male and female role), Egg freezing ,Abortion Care, Contraception (male and female), Embryo transfer
  • Pregnancy and Maternal health
    Discussing: Prenatal disease, Pre-eclampsia, Maternal Mortality, Post-partum care, Mental Health, Childbirth, OBGYN services
  • Reproductive Health Issues/Changes
    Breaking down: PCOS, Endometriosis, BV, Low sperm count, Erectile dysfunction, Vaginal Microbiome, Heavy menstrual bleeding and PMS, STI/Sexual Health, Uterine Fibroids, Cancer, Hormonal Health

2024 SPEAKERS

 

Margaret Malone

Healthtech Investor
Flare Capital

Margaret Malone

Healthtech Investor
Flare Capital

Margaret Malone

Healthtech Investor
Flare Capital
 

Vrunda Desai

MD, FACOG, Vice President of Medical Affairs,
CooperSurgical

Vrunda Desai

MD, FACOG, Vice President of Medical Affairs,
CooperSurgical

Vrunda Desai

MD, FACOG, Vice President of Medical Affairs,
CooperSurgical
 

Bethany Corbin

Founder & CEO
FemInnovation

Bethany Corbin

Founder & CEO
FemInnovation

Bethany Corbin

Founder & CEO
FemInnovation
 

Fahimeh Sasan

Chief Innovation Officer
Kindbody

Fahimeh Sasan

Chief Innovation Officer
Kindbody

Fahimeh Sasan

Chief Innovation Officer
Kindbody
 

Liza Kunz

Systems Director, Endocrinology & Reproductive Health
Abbott

Liza Kunz

Systems Director, Endocrinology & Reproductive Health
Abbott

Liza Kunz

Systems Director, Endocrinology & Reproductive Health
Abbott
 

Ru-fong Joanne Cheng

Director, Women’s Health Innovations
Bill & Melinda Gates Foundation

Ru-fong Joanne Cheng

Director, Women’s Health Innovations
Bill & Melinda Gates Foundation

Ru-fong Joanne Cheng

Director, Women’s Health Innovations
Bill & Melinda Gates Foundation
 

Sasha Ottey, MHA, MT, (ASCP)

Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association

Sasha Ottey, MHA, MT, (ASCP)

Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association

Sasha Ottey, MHA, MT, (ASCP)

Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association
 

Leigh Allen

Program Officer
Eunice Kennedy Shriver National Institute of Child Health and Human Development

Leigh Allen

Program Officer
Eunice Kennedy Shriver National Institute of Child Health and Human Development

Leigh Allen

Program Officer
Eunice Kennedy Shriver National Institute of Child Health and Human Development
 

Everett Hanford

Region 1 Director of New England
U.S. Department of Health and Human Services

Everett Hanford

Region 1 Director of New England
U.S. Department of Health and Human Services

Everett Hanford

Region 1 Director of New England
U.S. Department of Health and Human Services
 

Daniel Johnston

Chief, Contraception Research Branch
Eunice Kennedy Shriver National Institute of Child Health and Human Development

Daniel Johnston

Chief, Contraception Research Branch
Eunice Kennedy Shriver National Institute of Child Health and Human Development

Daniel Johnston

Chief, Contraception Research Branch
Eunice Kennedy Shriver National Institute of Child Health and Human Development
 

David Sable

Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Life Sciences Portfolio Manager
Special Situations Funds
 

Carmen Messerlian

Founder & President
Vie Science, Inc.

Carmen Messerlian

Founder & President
Vie Science, Inc.

Carmen Messerlian

Founder & President
Vie Science, Inc.
 

Diana Contreras

Chief Health Strategy Officer
Planned Parenthood Federation of America

Diana Contreras

Chief Health Strategy Officer
Planned Parenthood Federation of America

Diana Contreras

Chief Health Strategy Officer
Planned Parenthood Federation of America
 

Jessica Bell van der Wal

Co-Founder and CEO
Frame Fertility

Jessica Bell van der Wal

Co-Founder and CEO
Frame Fertility

Jessica Bell van der Wal

Co-Founder and CEO
Frame Fertility
 

Nada Hanafi MSc, MPH

Founder & Manager, MedTech Strategy Advisors LLC; Co-Founder
MedTech Color

Nada Hanafi MSc, MPH

Founder & Manager, MedTech Strategy Advisors LLC; Co-Founder
MedTech Color

Nada Hanafi MSc, MPH

Founder & Manager, MedTech Strategy Advisors LLC; Co-Founder
MedTech Color
 

Kevin Eisenfrats

Co-Founder & CEO
Contraline

Kevin Eisenfrats

Co-Founder & CEO
Contraline

Kevin Eisenfrats

Co-Founder & CEO
Contraline
 

Anne Morrisey

CEO and Founder
May Health

Anne Morrisey

CEO and Founder
May Health

Anne Morrisey

CEO and Founder
May Health
 

Yaron Silberman

CEO
BAIBYS™ Fertility

Yaron Silberman

CEO
BAIBYS™ Fertility

Yaron Silberman

CEO
BAIBYS™ Fertility
 

Mary Frank

Director of Strategic Initiatives
National Abortion Federation

Mary Frank

Director of Strategic Initiatives
National Abortion Federation

Mary Frank

Director of Strategic Initiatives
National Abortion Federation
 

Michelle Perugini

CEO & Co-Founder
Presagen

Michelle Perugini

CEO & Co-Founder
Presagen

Michelle Perugini

CEO & Co-Founder
Presagen
 

Anita Garg

Senior Director Strategy
Population Council

Anita Garg

Senior Director Strategy
Population Council

Anita Garg

Senior Director Strategy
Population Council
 

Christy Prada

CEO
Future Fertility

Christy Prada

CEO
Future Fertility

Christy Prada

CEO
Future Fertility
 

Heather Bowerman

CEO and Founder
DotLab

Heather Bowerman

CEO and Founder
DotLab

Heather Bowerman

CEO and Founder
DotLab
 

Naseem Sayani

Co-Founder & Managing Director
Emmeline Ventures

Naseem Sayani

Co-Founder & Managing Director
Emmeline Ventures

Naseem Sayani

Co-Founder & Managing Director
Emmeline Ventures
 

Donna Russell

CEO
Precia Group

Donna Russell

CEO
Precia Group

Donna Russell

CEO
Precia Group
 

Stasia Obremskey

Managing Director
RH Capital

Before joining, Stasia served in 2018 as the first Fellow of the Tara Health Foundation. She has more than twenty-five years of experience providing financial and strategic planning consulting to organizations in the U.S. and Asia. She has joined management teams as the interim Chief Financial Officer on a short term and extended term basis to provide finance, accounting and strategic planning expertise to startups, fast growing companies and non-profit organizations. Current and past clients include 18Birdies, Posit Science, Circlepoint, West Shore Technologies and We Care Solar.

Stasia Obremskey

Managing Director
RH Capital

Stasia Obremskey

Managing Director
RH Capital

Before joining, Stasia served in 2018 as the first Fellow of the Tara Health Foundation. She has more than twenty-five years of experience providing financial and strategic planning consulting to organizations in the U.S. and Asia. She has joined management teams as the interim Chief Financial Officer on a short term and extended term basis to provide finance, accounting and strategic planning expertise to startups, fast growing companies and non-profit organizations. Current and past clients include 18Birdies, Posit Science, Circlepoint, West Shore Technologies and We Care Solar. She has lived for over 8 years in Bangkok, Thailand and Hong Kong, China. She began her consulting career as a management consultant with Bain & Company. Previously, she worked in investment banking for Morgan Stanley & Co. She holds a bachelor’s degree in Business Administration with a concentration in finance from the University of Notre Dame and an MBA from the Harvard Graduate School of Business. In addition to her consulting work, she has extensive experience as a member of several nonprofit boards where she has held a number of leadership positions.

 

Natalie Birnbaum

Principal Owner, Attorney
Repro Solutions

Natalie Birnbaum

Principal Owner, Attorney
Repro Solutions

Natalie Birnbaum

Principal Owner, Attorney
Repro Solutions
 

Kristin Brogaard

CSO & Co-Founder
Inherent Biosciences Inc.

Kristin Brogaard

CSO & Co-Founder
Inherent Biosciences Inc.

Kristin Brogaard

CSO & Co-Founder
Inherent Biosciences Inc.
 

Ashley Crafton

CEO and Founder
Galena Innovations

Ashley Crafton

CEO and Founder
Galena Innovations

Ashley Crafton

CEO and Founder
Galena Innovations
 

Valerie Palmieri

CEO
MOMENTUM Consulting

Valerie Palmieri

CEO
MOMENTUM Consulting

Valerie Palmieri

CEO
MOMENTUM Consulting
 

Nader AlSalim

Founder & CEO
Gaia

Nader AlSalim

Founder & CEO
Gaia

Nader AlSalim

Founder & CEO
Gaia
 

Samantha Miller

Co-Founder & Co-CEO
Cadence Health

Samantha Miller

Co-Founder & Co-CEO
Cadence Health

Samantha Miller

Co-Founder & Co-CEO
Cadence Health
 

Nigina Nuntean

Head of Innovation Unit
United Nations Population Fund

Nigina Nuntean

Head of Innovation Unit
United Nations Population Fund

Nigina Nuntean

Head of Innovation Unit
United Nations Population Fund
 

Monica Cepak

CEO
Wisp

Monica Cepak

CEO
Wisp

Monica Cepak

CEO
Wisp
 

Mark Connell

President
SLBST Pharma

Mark Connell

President
SLBST Pharma

Mark Connell

President
SLBST Pharma
 

Asima Ahmad

Co-Founder & Chief Medical Officer
Carrot Fertility

Asima Ahmad

Co-Founder & Chief Medical Officer
Carrot Fertility

Asima Ahmad

Co-Founder & Chief Medical Officer
Carrot Fertility
 

Andrea Olariu

CEO
Medicines360

Andrea Olariu

CEO
Medicines360

Andrea Olariu

CEO
Medicines360
 

David Stern

CEO
Boston IVF

David Stern has over 28 years of women’s health experience and has devoted the majority of his career to the fertility industry. He has held executive leadership positions and built successful teams while launching numerous products in pharmaceutical and biotech markets world-wide. Currently, David serves as the CEO of Boston IVF, one the largest IVF center networks in the United States with 11 full service IVF centers and over 30 satellite centers nationwide.

 

David Stern

CEO
Boston IVF

David Stern

CEO
Boston IVF

David Stern has over 28 years of women’s health experience and has devoted the majority of his career to the fertility industry. He has held executive leadership positions and built successful teams while launching numerous products in pharmaceutical and biotech markets world-wide. Currently, David serves as the CEO of Boston IVF, one the largest IVF center networks in the United States with 11 full service IVF centers and over 30 satellite centers nationwide.

 

David served as CEO of Symbiomix Therapeutics a venture backed biotech company. He led the transition of the company from development stage to commercial launch in the US, prior to its acquisition by Lupin Pharmaceuticals in 2017. He served on the board of California Cryobank and has held executive positions in startup companies in the women’s healthcare market, building commercial teams, developing strategy and expanding scientific partnerships for Celmatix, Ohana and OvaScience.

 

David was the Senior Vice President and Head of the Global Business Franchise for Fertility at Merck Serono, responsible for the strategic development and growth of the portfolio world-wide. Prior to his global role, he was responsible for the US commercial operations in the Fertility, HIV and Growth Hormone markets. David started his career in women’s health with Organon Pharmaceutics. He has an MBA with a concentration in International Marketing and Management from the F.W. Olin School of Business at Babson College and holds a Bachelors’ degree in Biology from Brandeis University.

 

April Schweitzer

Partner
Nixon Peabody

April Schweitzer is a partner in Nixon Peabody’s Healthcare practice group and is based of Chicago. She partners with provider clients to address corporate and regulatory issues affecting hospitals, health systems, and physician groups. She also provides counsel regarding value-based contracting, clinical integration networks, and accountable care organizations. Specifically, April works with clients on transactional matters including mergers, acquisitions, and joint ventures, as well as corporate governance, licensure, tax exemption, and formation issues.

April Schweitzer

Partner
Nixon Peabody

April Schweitzer

Partner
Nixon Peabody

April Schweitzer is a partner in Nixon Peabody’s Healthcare practice group and is based of Chicago. She partners with provider clients to address corporate and regulatory issues affecting hospitals, health systems, and physician groups. She also provides counsel regarding value-based contracting, clinical integration networks, and accountable care organizations. Specifically, April works with clients on transactional matters including mergers, acquisitions, and joint ventures, as well as corporate governance, licensure, tax exemption, and formation issues. She also provides counsel to clients regarding EMTALA, the federal Anti-Kickback Statute, the federal Stark law, and state law equivalents, and Medicare and Medicaid regulatory compliance, including voluntary self-disclosures.

 

Juan Camilo Arjona Ferreira

Head of Research & Development and Chief Medical Officer
Organon

Juan Camilo Arjona Ferreira

Head of Research & Development and Chief Medical Officer
Organon

Juan Camilo Arjona Ferreira

Head of Research & Development and Chief Medical Officer
Organon
 

Alexandra Busto

Partner
Nixon Peabody LLP

Alex Busto is a senior associate in Nixon Peabody’s Healthcare practice group and is based out of Los Angeles. She works with academic medical centers, hospitals, surgery centers, foundations and clinics, medical groups/IPAs, in-vitro fertilization and reproductive service providers, telehealth companies, MSOs, and other entities affiliated with the healthcare industry. Alex works closely with clients on transactional matters, and advises on multi-state expansion and growth, hospital/physician alignment, joint ventures, acquisitions, and other strategic transactions.

Alexandra Busto

Partner
Nixon Peabody LLP

Alexandra Busto

Partner
Nixon Peabody LLP

Alex Busto is a senior associate in Nixon Peabody’s Healthcare practice group and is based out of Los Angeles. She works with academic medical centers, hospitals, surgery centers, foundations and clinics, medical groups/IPAs, in-vitro fertilization and reproductive service providers, telehealth companies, MSOs, and other entities affiliated with the healthcare industry. Alex works closely with clients on transactional matters, and advises on multi-state expansion and growth, hospital/physician alignment, joint ventures, acquisitions, and other strategic transactions. In connection with these transactions, her practice also includes providing regulatory counsel with respect to federal and state compliance with physician self-referral, anti-kickback, licensing and certification, and other healthcare compliance matters.

 

Charlotte Owens

Head of Medical Affairs & Outcomes Research
Organon

Charlotte Owens

Head of Medical Affairs & Outcomes Research
Organon

Charlotte Owens

Head of Medical Affairs & Outcomes Research
Organon
 

Dr Lyndsey Harper MD, FACOG IF

Founder & CEO
Rosy Wellness

Dr Lyndsey Harper MD, FACOG IF

Founder & CEO
Rosy Wellness

Dr Lyndsey Harper MD, FACOG IF

Founder & CEO
Rosy Wellness
 

Maia Gokhale

Vice President, Partner Success
Mae

Maia Gokhale

Vice President, Partner Success
Mae

Maia Gokhale

Vice President, Partner Success
Mae
 

Thomas F. McElrath

Associate Professor, Harvard Medical School
Brigham and Women’s Hospital

Thomas F. McElrath, MD, PhD:  Dr McElrath is a Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a Professor of Epidemiology at the Harvard TH Chan School of Public Health. For 25 years he has served as an attending physician in Maternal-Fetal Medicine at The Brigham and Women’s Hospital in Boston where he is the Director of the Preterm Birth Clinic and Principal Investigator of the LIFECODES birth cohort.

Thomas F. McElrath

Associate Professor, Harvard Medical School
Brigham and Women’s Hospital

Thomas F. McElrath

Associate Professor, Harvard Medical School
Brigham and Women’s Hospital

Thomas F. McElrath, MD, PhD:  Dr McElrath is a Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a Professor of Epidemiology at the Harvard TH Chan School of Public Health. For 25 years he has served as an attending physician in Maternal-Fetal Medicine at The Brigham and Women’s Hospital in Boston where he is the Director of the Preterm Birth Clinic and Principal Investigator of the LIFECODES birth cohort. He has a PhD in Mathematical Demography with ongoing research interests in two areas: the effects of environmental toxicant exposures in pregnancy and the utilization of biomarkers for the prediction of preterm birth and associated pregnancy complications.

 

Dr. Sophia Yen

Co-founder and Chief Medical Officer
Pandia Health

Dr. Sophia Yen

Co-founder and Chief Medical Officer
Pandia Health

Dr. Sophia Yen

Co-founder and Chief Medical Officer
Pandia Health

TESTIMONIALS & SUCCESS STORIES

INNOVATION SHOWCASE

Now in its 4th iteration, we’ve decided to shake things up! This year, across two days, 10 reproductive health startups will be picked by our prestigious selection committee of investors to take to the stage in front of strategic partners and potential collaborators. Each startup will have 5 minutes to demonstrate their vision of the future of reproductive health and how their product, technology, or service fits into it. This will be followed by 5 minutes of live Q&A led by a panel of expert investor judges. At the end of each showcase, the winner will be selected based on a combined audience and judges vote and receive a prize bundle.

Applications closed.

Thank you to our investors:

Academic Poster Session

Apply to showcase your innovative research within reproductive health. Up to 10 academic posters will be displayed to our audience of potential partners, funders, and accelerators. 

Apply here

2023 ADVISORY BOARD

Author:

Alice Zheng

Principal
RH Capital

Alice Zheng

Principal
RH Capital

Author:

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Author:

Elizabeth Garner

MD, MPH, Chief Scientific Officer, US
Ferring Pharmaceuticals

Elizabeth Garner

MD, MPH, Chief Scientific Officer, US
Ferring Pharmaceuticals

Author:

Kalahn Taylor-Clark

Faculty in Executive Education
The Johns Hopkins University

Kalahn Taylor-Clark

Faculty in Executive Education
The Johns Hopkins University

Author:

Jamie White

Health Science Strategist

Jamie White

Health Science Strategist

Author:

Raymon uit de Bulten

Venture Leader
Philips

Raymon uit de Bulten

Venture Leader
Philips

Author:

Lucy Perez

PhD, Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Lucy Perez

PhD, Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Author:

Sandy Milligan

MD, JD, Head of R&D
Organon

Sandy Milligan

MD, JD, Head of R&D
Organon

Author:

Valerie Palmieri

CEO & Founder
MOMENTUM Consulting

Valerie Palmieri

CEO & Founder
MOMENTUM Consulting

Author:

Rachel Braun Scherl

Co-Founder & Managing Partner
SPARK Solutions for Growth

Rachel Braun Scherl

Co-Founder & Managing Partner
SPARK Solutions for Growth

Author:

Anula Jayasuriya

CoFounder
Kidron Capital

Anula Jayasuriya

CoFounder
Kidron Capital

AUDIENCE BREAKDOWN

  • Start Ups

    We are committed to increasing exposure of emerging companies in reproductive health, at all stages of growth and development who are seeking partnership opportunities and are at the forefront of shaping the
    future of this space.

    30%
  • Big Pharma/Medical Device/Biotech

    At the forefront of women’s health innovation, Big Pharma, Medical Device, and Biotech companies play a key role in shaping the investments and innovation happening in the reproductive health sphere.

     

    25%
  • Investor, Funding Groups

    We look to bring together leading investors with a particular focus in reproductive health, ranging from seed, to angel, venture capital firms, private equity, funds, and advisors.

    20%
  • Payers, Providers, Employers

    Payors, insurance companies, and benefit providers provide an important bridge between stakeholders within the reproductive health industry, and we are delighted to have more joining us at this years’ summit.

    5%
  • Service Providers

    Industry support and service providers include advocacy groups, researchers, knowledge leaders and accelerators such as consultants, lawyers, CROs, non-profits and regulatory experts

    15%
  • FMCGs

    Fast moving consumer goods companies play an important role in the reproductive health landscape, and the women’s health landscape more broadly, and include companies such as Johnson & Johnson and Holland & Barrett.

    5%

2024 PARTNERS

HEADLINE PARTNER

PLATINUM PARTNER

GOLD PARTNER

EVENT PARTNERS

VIP NETWORKING PARTNER

MEDIA PARTNERS

PARTNERING OPPORTUNITIES

The Reproductive Health Innovation Summit is an opportunity to strengthen and elevate your position in a growing market, which is ripe for partnerships and investment.

Based on your objective, we can create bespoke packages tailored specifically to you. From presenting your expertise, hosting a panel discussion, virtual networking booths, exclusive pitching sessions or webinars. We’re dedicated to helping you showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories:

THOUGHT LEADERSHIP                                   BRANDING                                   NETWORKING

For any Partnering Opportunities enquiries, please contact Sam Grimsley.

       +44 (0)20 3897 9536          [email protected]

DOWNLOAD OUR 2024 AGENDA

Download the 2024 Agenda Now!


Download agenda

REGISTER

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

Registration closes in

Preparing registration...

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Other events you might be interested in:

Women's Healthy Aging Innovation Summit

Women's Health Innovation Summit, Europe

Women's Health Innovation Summit 2024